-
1
-
-
4444224484
-
Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety
-
Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenteroll Hepatol. 2004;2:731-743.
-
(2004)
Clin Gastroenteroll Hepatol
, vol.2
, pp. 731-743
-
-
Dubinsky, M.C.1
-
2
-
-
33748555869
-
Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center
-
Banerjee S. Bishop WP. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center. J Pediatr Gastroenterol Nutr. 2006;43:353-356.
-
(2006)
J Pediatr Gastroenterol Nutr
, vol.43
, pp. 353-356
-
-
Banerjee, S.1
Bishop, W.P.2
-
3
-
-
0029134702
-
Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
-
Pearson DC, May GR, Fick GH, et. al. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med. 1995; 123:1321-142.
-
(1995)
Ann Intern Med
, vol.123
, pp. 1321-2142
-
-
Pearson, D.C.1
May, G.R.2
Fick, G.H.3
et., al.4
-
4
-
-
0034023321
-
A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: Origins at the Mount Sinai Hospital
-
Korelitz BI. A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at the Mount Sinai Hospital. Mt Sinai J Med. 2000;67:214-226.
-
(2000)
Mt Sinai J Med
, vol.67
, pp. 214-226
-
-
Korelitz, B.I.1
-
6
-
-
0019782219
-
-
Theodor E, Niv Y, Bat L. Imuran in the treatment of ulcerative colitis. Am J Gastroenterol. 1981;76:262-266.
-
Theodor E, Niv Y, Bat L. Imuran in the treatment of ulcerative colitis. Am J Gastroenterol. 1981;76:262-266.
-
-
-
-
7
-
-
0034036355
-
Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease
-
Kader HA, Wenner WJ Jr, Telega GW, et al. Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease. J Clin Gastroenterol. 2000;30:409-413.
-
(2000)
J Clin Gastroenterol
, vol.30
, pp. 409-413
-
-
Kader, H.A.1
Wenner Jr, W.J.2
Telega, G.W.3
-
8
-
-
0037246773
-
Mercaptopurine metabolite results in clinical gastroenterology practice
-
Bloomfeld RS, Onken JE. Mercaptopurine metabolite results in clinical gastroenterology practice. Aliment Pharmacol Ther. 2003;17:69-73.
-
(2003)
Aliment Pharmacol Ther
, vol.17
, pp. 69-73
-
-
Bloomfeld, R.S.1
Onken, J.E.2
-
9
-
-
0034067784
-
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
-
Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705-713.
-
(2000)
Gastroenterology
, vol.118
, pp. 705-713
-
-
Dubinsky, M.C.1
Lamothe, S.2
Yang, H.Y.3
-
10
-
-
33646011261
-
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
-
Osterman MT, Kundu R, Lichtenstein GR, et al. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology. 2006;130:1047-1053.
-
(2006)
Gastroenterology
, vol.130
, pp. 1047-1053
-
-
Osterman, M.T.1
Kundu, R.2
Lichtenstein, G.R.3
-
11
-
-
0037237923
-
Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD
-
Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord. 2003;3(suppl 1):S30-38.
-
(2003)
Rev Gastroenterol Disord
, vol.3
, Issue.SUPPL. 1
-
-
Seidman, E.G.1
-
12
-
-
33846820178
-
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine
-
Sparrow MP, Hande SA, Friedman S, et al. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol. 2007;5: 209-214.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 209-214
-
-
Sparrow, M.P.1
Hande, S.A.2
Friedman, S.3
-
13
-
-
24344480999
-
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine
-
Sparrow MP, Hande SA, Friedman S, et al. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther. 2005;22:441-446.
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 441-446
-
-
Sparrow, M.P.1
Hande, S.A.2
Friedman, S.3
-
14
-
-
0033794050
-
Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine
-
Bowen D, Selby W. Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine. Dig Dis Sci. 2000;45:1810-1813.
-
(2000)
Dig Dis Sci
, vol.45
, pp. 1810-1813
-
-
Bowen, D.1
Selby, W.2
-
15
-
-
0027161587
-
Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen
-
Chocair P, Duley J, Simmonds HA, et al. Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen. Lancet. 1993;342:83-84.
-
(1993)
Lancet
, vol.342
, pp. 83-84
-
-
Chocair, P.1
Duley, J.2
Simmonds, H.A.3
-
16
-
-
28844490574
-
Observations on the use of allopurinol in combination with azathioprine or mercaptopurine
-
Duley JA, Chocair PR, Florin TH. Observations on the use of allopurinol in combination with azathioprine or mercaptopurine. Aliment Pharmacol Ther. 2005;22:1161-1162
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 1161-1162
-
-
Duley, J.A.1
Chocair, P.R.2
Florin, T.H.3
-
17
-
-
61649106169
-
-
Allopurinol. In: DRUGDEX Evaluations [intranet database]. Version 5.1. Greenwood Village, CO: Thomson Healthcare. Accessed March 24, 2008.
-
Allopurinol. In: DRUGDEX Evaluations [intranet database]. Version 5.1. Greenwood Village, CO: Thomson Healthcare. Accessed March 24, 2008.
-
-
-
|